+++

title = "Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine"

date = 2021-08-16

summary = "Pfizer and BioNTech submitted Phase 1 data as a part of their Phase 1/2/3 clinical trial program supporting the evaluation of a third or booster dose."

tags = ["News", "Pfizer"]

category = "News"

+++

Pfizer and BioNTech annouced the submission of Phase 1 data which displayed that individuals who received a third dose of the Pfizer-BioNTech vaccine indicates that the third dose may exceed protection and elicit higher neutralizing antibodies against the virus and the Beta and Delta variants. Therefore, Pfizer says that a booster dose given within 6 to 12 months after the primary vaccination schedule may help maintain a high level of protection against COVID-19.

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-submission-initial-data-us-fda
